This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Is Methode (MEI) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
U.S. Manufacturing Sector Grows in March: ETF & Stock Picks
by Sanghamitra Saha
U.S. Manufacturing PMI increased to 55.3 in March from February???s 54.2 and beat expectations. These industry ETFs and stocks could be good picks in an improving backdrop.
Top Ranked Value Stocks to Buy for April 1st
by Zacks Equity Research
Here are four stocks with buy rank and strong value characteristics for investors to consider today, April 1st
Zacks.com featured expert Kevin Matras highlights: Methode Electronics, Walker & Dunlop, Marker Therapeutics, Chemed and Olympic Steel
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Methode Electronics, Walker & Dunlop, Marker Therapeutics, Chemed and Olympic Steel
Top-Ranked Stocks to Fill in the Sweet 16 Bracket
by Sweta Killa
We have enthusiastically filling in the March Madness brackets that could lead to handsome returns from the stocks that are wagered on.
These 5 Stocks Make Great Buys on New Analyst Coverage
by Shrabana Mukherjee
Increased analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.
New Strong Buy Stocks for March 28th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Has Methode Electronics (MEI) Outpaced Other Computer and Technology Stocks This Year?
by Zacks Equity Research
Is (MEI) Outperforming Other Computer and Technology Stocks This Year?
Are Investors Undervaluing Methode (MEI) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Amtek (AME) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Amtek (AME) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
How Methode (MEI) Stock Stands Out in a Strong Industry
by Zacks Equity Research
Methode (MEI) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Zacks.com featured expert Kevin Matras highlights: Balchem, Methode Electronics, Chemed, Ubiquiti Networks and HEXO
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Balchem, Methode Electronics, Chemed, Ubiquiti Networks and HEXO
5 Stocks in Focus on New Analysts Coverage
by Zacks Equity Research
Increased analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.
What Falling Estimates & Price Mean for Methode Electronics (MEI)
by Zacks Equity Research
Methode Electronics (MEI) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
Methode (MEI) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Methode (MEI) delivered earnings and revenue surprises of 11.94% and 1.70%, respectively, for the quarter ended October 2018. Do the numbers hold clues to what lies ahead for the stock?
Why the Earnings Surprise Streak Could Continue for Methode (MEI)
by Zacks Equity Research
Methode (MEI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Methode (MEI) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Methode (MEI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Methode (MEI) Q1 Earnings Surpass Estimates
by Zacks Equity Research
Methode (MEI) delivered earnings and revenue surprises of 10.53% and -2.71%, respectively, for the quarter ended July 2018. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for July 27th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Red Hat (RHT) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Red Hat's (RHT) first-quarter fiscal 2019 earnings are likely to benefit from solid partner base and strong traction of OpenShift.
Top Ranked Growth Stocks to Buy for June 18th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, June 18th:
Amphenol (APH) Q1 Earnings Beat on Strong Organic Growth
by Zacks Equity Research
Amphenol (APH) revenues were driven by strong organic growth across most of the end markets, in particular, mobile devices, military, industrial, automotive, and commercial air.
New Strong Buy Stocks for November 28th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
Marvell (MRVL) Q3 Earnings: What Lies Ahead for the Stock?
by Zacks Equity Research
Strong demand for Marvell's (MRVL) 4G LTE products and acquisition synergies are likely to act as catalysts to Q3 results.
Amphenol (APH) Hits 52-Week High on Bullish Growth Trends
by Zacks Equity Research
Improved end-market demand, bullish outlook for 2017 and core focus perhaps boosted investors' confidence and catapulted Amphenol's (APH) shares to a new 52-week high.